An eGFR of 42 means your kidneys are filtering blood at roughly 42 percent of what a healthy young adult’s kidneys would, placing you squarely in what clinicians call Stage 3b chronic kidney disease (CKD). That stage covers eGFR values between 30 and 44 and represents a moderately-to-severely reduced level of kidney function. It is not yet kidney failure, but it sits at a threshold where the risks of further decline, cardiovascular complications, and medication problems all climb steeply enough that active management makes a real difference.
Where 42 Falls on the CKD Staging Map
Kidney function is graded on a scale from Stage 1 (normal or high filtration, eGFR above 90) down through Stage 5 (kidney failure, eGFR below 15). Stage 3 is split in two because the clinical picture changes meaningfully across its range. Stage 3a covers eGFR 45 to 59 and is often described as mild-to-moderate loss. Stage 3b, which includes an eGFR of 42, covers 30 to 44 and is considered moderate-to-severe loss. The split matters because outcomes worsen as you cross from 3a into 3b. Research on kidney transplant recipients, for example, has identified factors like older donor age, delayed graft function, and certain infections as contributors that push transplanted kidneys into that 30-to-44 range rather than the higher 45-to-59 tier, underscoring that the biology at these two substages genuinely differs.1Wiley Online Library. Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function
An eGFR of 42 also sits above the threshold at which most guidelines traditionally trigger a nephrology referral. The KDIGO guidelines from 2013 recommend referral when eGFR is persistently below 30, meaning many people with an eGFR around 42 are initially managed by their primary care doctor rather than a kidney specialist.2PubMed Central. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease That arrangement can work well when the decline is slow and predictable, but it also means you need to understand what your number represents and what trajectory it’s on.
What the Number Actually Estimates
eGFR stands for estimated glomerular filtration rate. Your kidneys contain millions of tiny filtering units, and the GFR measures how much blood those filters process per minute. Because measuring GFR directly requires injecting a tracer substance and collecting timed samples, clinicians almost always estimate it using a formula that takes your blood creatinine level, age, and sex into account. The most widely used formula in adults is the CKD-EPI equation.
The word “estimated” deserves emphasis. Creatinine is a waste product from muscle metabolism, so your muscle mass influences the result. A very muscular person can have a slightly lower eGFR than their actual kidney function warrants, and a person with very little muscle mass can look better on paper than they really are. Cystatin C, a different blood marker, is virtually uninfluenced by muscle mass and can give a more accurate picture in cases where creatinine-based estimates seem off.3PubMed Central. Muscle mass, creatinine, cystatin C and selective glomerular hypofiltration syndromes If you have unusually high or low muscle mass, or if your eGFR seems inconsistent with your symptoms, your doctor may order a cystatin C test to get a clearer reading.
Formula choice can also shift the number. The updated 2021 CKD-EPI equation removed the race coefficient that was part of the older version, and research has shown that switching between the two equations can reclassify a meaningful percentage of patients. In one cohort, up to 29 percent of patients who met CKD criteria under the older equation no longer did under the 2021 version, particularly near the 60 mL/min boundary between Stages 2 and 3a.4PubMed Central. When equations disagree: the impact of creatinine-based eGFR in CKD diagnosis and reclassification At your level of 42, equation differences are less likely to flip your stage entirely, but they are a reminder that eGFR is a best-guess number, not a laboratory-grade measurement.
How You Might Feel at an eGFR of 42
One of the frustrating things about Stage 3b is that many people feel largely normal. Kidneys have enormous reserve capacity, and they compensate for damage for a long time before obvious symptoms break through. That said, some people at this stage do begin to notice fatigue that does not respond to rest, mild swelling in the ankles or feet, changes in how often or how much they urinate (especially at night), and muscle cramps. These symptoms tend to creep in gradually rather than arrive all at once.
Blood tests often tell a more detailed story than your body does. At an eGFR of 42, you might start to see rising phosphorus levels, falling calcium or vitamin D, a slight dip in hemoglobin (a form of anemia), and increasing levels of parathyroid hormone. These metabolic shifts happen because your kidneys handle far more than waste removal; they regulate minerals, help produce red blood cells, and activate vitamin D. When filtering capacity drops to about 40 percent, those secondary jobs begin to suffer too.
Is This Just Aging or Actual Disease?
Kidney function does decline with age in healthy people, and this is one of the more contentious areas in nephrology. A systematic review of the normal rate of kidney function decline found that healthy adults without high blood pressure lose somewhere between about 0.4 and 1.1 mL/min per year.5PubMed Central. Rate of decline in kidney function with age: a systematic review That means a healthy 80-year-old who started at an eGFR of 110 in their twenties could plausibly drift down to the low 60s or even upper 50s purely from aging, but dropping all the way to 42 from age alone would be unusual without other contributing factors.
The current diagnostic cutoff for CKD is an eGFR below 60, and it does not adjust for age. The same review noted this limitation, pointing out that a flat threshold may over-diagnose CKD in elderly people whose kidneys are declining at a normal rate. But for someone at 42, the question shifts somewhat. Whether or not the exact label of “CKD” is appropriate for a healthy 85-year-old with stable kidney function in the upper 50s, an eGFR of 42 almost always indicates that something beyond normal aging is contributing, whether that is diabetes, longstanding high blood pressure, a past episode of kidney injury, or another condition.
The Cardiovascular Connection
People often think of CKD as strictly a kidney problem, but at Stage 3b, your cardiovascular risk climbs substantially. This is not just a theoretical concern. A large study tracking changes in eGFR over time found that among people with eGFR between 30 and 59, those whose kidney function was declining the fastest had roughly four to five times the risk of dying compared with those whose function was stable.6PubMed Central. Change in Estimated GFR Associates with Coronary Heart Disease and Mortality That same study linked faster eGFR decline to coronary heart disease events as well. The mechanism involves several overlapping pathways: kidneys help regulate blood pressure, fluid balance, and mineral metabolism, and as they struggle, those systems become less stable, which stresses the heart and blood vessels.
This is why managing CKD at your stage is not just about protecting your kidneys from further decline. It is equally about protecting your heart. Blood pressure control, cholesterol management, and blood sugar control in people with diabetes all become even more important as eGFR drops into the 40s.
Treatments That Slow the Decline
The treatment landscape for CKD has improved substantially in recent years. For decades, blood pressure medications called ACE inhibitors and ARBs were essentially the only drugs shown to slow kidney function loss. They remain a cornerstone of treatment, but they are no longer alone.
SGLT2 inhibitors, originally developed for diabetes, have turned out to be powerful kidney protectors in people with CKD regardless of whether they have diabetes. Major trials showed that adding an SGLT2 inhibitor on top of standard treatment in people with CKD who had protein in their urine could reduce the annual rate of eGFR loss to around 2 to 2.5 mL/min per year, and in people without excess protein in the urine, the annual loss dropped to less than 0.5 mL/min, which is actually slower than what many healthy adults lose from aging alone.7PubMed Central. Use of ACEi/ARBs, SGLT2 inhibitors and MRAs can help us reach the therapeutic ceiling in CKD Finerenone, a newer type of mineralocorticoid receptor antagonist, has shown additional benefit in people with CKD and type 2 diabetes.
That said, not everyone responds equally. Despite the impressive trial results, a substantial proportion of patients remains at high risk of further kidney decline and cardiovascular events even with all available therapies on board.8Clinical Kidney Journal. The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? The evidence is clear that these treatments help on average, but they do not guarantee stability for every individual. Monitoring your eGFR trend over time, rather than fixating on any single number, is how your doctor gauges whether your treatment is working.
Why Getting Diagnosed Sooner Matters
If you have just received an eGFR of 42 and this is the first time anyone has mentioned CKD to you, you are not alone. CKD in its earlier stages is chronically under-diagnosed and under-treated. But the data on what happens once a diagnosis is formally made and acted upon is striking. A large observational study of people with Stage 3 CKD found that after a recorded diagnosis, prescribing rates of guideline-recommended medications roughly doubled. More to the point, the annual rate of eGFR decline dropped from about 3.2 mL/min per year before diagnosis to about 0.7 mL/min per year afterward.9PubMed Central. Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study
That same research found that each year of delayed diagnosis was associated with a 40 percent higher risk of progressing to Stage 4 or 5, and a 63 percent higher risk of kidney failure. Delayed diagnosis also increased the risk of heart attack, stroke, and heart failure hospitalizations.9PubMed Central. Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study The takeaway here is plain: the number 42 on a lab report is not just a diagnosis to absorb psychologically. It is a cue to make sure treatment is optimized right now, not after the next decline.
When You Should See a Kidney Specialist
The traditional referral threshold of eGFR below 30 means many people in Stage 3b get managed by primary care. But several situations at an eGFR of 42 warrant earlier referral to a nephrologist. These include a rapid drop in eGFR (a sustained decrease of 15 or more mL/min per year), significant protein in the urine, blood pressure that does not respond to multiple medications, persistent potassium abnormalities, anemia that is hard to explain, or any suspicion of a genetic or unusual kidney disease.2PubMed Central. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease
Updated guidelines from the UK’s NICE have moved away from a fixed eGFR threshold and now recommend referral based on a person’s five-year risk of needing dialysis or transplant, calculated using the Kidney Failure Risk Equation (KFRE). This risk-based approach accounts for age, sex, eGFR, and the amount of protein in the urine, and it can identify people at high risk who would be missed by the eGFR-below-30 rule alone. If you are at an eGFR of 42 with heavy proteinuria, your five-year risk could easily exceed the 5 percent threshold that triggers referral under these newer criteria.
Can an eGFR of 42 Be Temporary?
Sometimes a low eGFR reflects a reversible problem rather than chronic damage. Dehydration, a sudden drop in blood pressure, a urinary tract obstruction, or a reaction to a medication can all cause acute kidney injury that temporarily pushes your eGFR down. If the cause is identified and corrected quickly, kidney function may bounce back. However, research has also shown that acute episodes can sometimes leave lasting damage. A study on seasonal blood pressure drops, for instance, documented cases where a summertime dip in blood pressure led to acute kidney injury with irreversible reduction in GFR.10PubMed. Blood pressure drop in summer may cause acute kidney injury with irreversible reduction of glomerular filtration rate
If your eGFR of 42 is a first-time finding and was measured during an illness, surgery, or period of dehydration, your doctor will likely repeat the test after you have recovered. Two or more readings below 60 over a span of at least three months is the standard for confirming a CKD diagnosis. A single reading alone does not mean you have chronic kidney disease, but it does mean follow-up is essential.
Medication Adjustments You Need to Know About
At an eGFR of 42, your kidneys clear drugs from your body more slowly than normal. This affects a wide range of common medications, and failing to adjust doses can lead to drug accumulation and side effects. Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen are among the most important to be cautious with because they can reduce blood flow to the kidneys and accelerate damage. Certain antibiotics, diabetes medications (especially metformin, which has dose limits based on eGFR), and some blood pressure drugs also need dose changes at this level of function.11PubMed Central. Drug Therapies Affecting Renal Function: An Overview
This is an area where proactive communication with your pharmacist or doctor pays off. Every time you start a new medication, including over-the-counter products, mention your eGFR. Many pharmacies now flag renal dosing automatically if your kidney function is on file, but the system is not foolproof.
Dietary Considerations at Stage 3b
Dietary management becomes more relevant at an eGFR of 42 than at higher levels. Protein intake is one of the main targets. Eating large amounts of protein generates more waste products that your kidneys have to filter, and lowering protein intake has been a long-studied strategy for slowing CKD progression. Research on people with Stage 3b and beyond has examined low-protein diets with supplemental fiber, finding that a protein intake of roughly 0.7 grams per kilogram of body weight per day can reduce levels of certain toxic waste products that accumulate in CKD.12PubMed. Low-protein diet supplemented with inulin lowers protein-bound toxin levels in patients with stage 3b-5 chronic kidney disease: a randomized controlled study
Beyond protein, you should pay attention to sodium, potassium, and phosphorus. Sodium control helps with blood pressure and fluid retention. Potassium and phosphorus become progressively harder for the kidneys to regulate as function drops, and at an eGFR in the low 40s, your doctor may start monitoring these levels and recommending adjustments. A renal dietitian can help you figure out a practical eating plan that does not feel like a punishment, which matters because people tend to abandon diets that are too restrictive.
Supplements and Hidden Risks
If you take dietary supplements, an eGFR of 42 changes the risk calculation. People with reduced kidney function are more vulnerable to harm from supplements for two reasons: some products are directly toxic to the kidneys, and others simply accumulate to dangerous levels because the kidneys cannot clear them fast enough.13American Journal of Kidney Diseases. Use of Dietary Supplements Potentially Harmful in Chronic Kidney Disease Herbal products are particularly concerning because they are not regulated for safety in the way prescription drugs are, and some contain compounds that are directly nephrotoxic.
High-dose vitamin C, for instance, can increase oxalate levels and contribute to kidney stones or oxalate deposits in the kidneys. Creatine supplements, popular in fitness circles, can raise blood creatinine and confuse eGFR monitoring even if they do not cause direct harm. And certain herbal remedies marketed for kidney “detox” or “cleansing” contain aristolochic acid or other toxins that can cause severe kidney damage. If you are taking any supplements, run them past your nephrologist or pharmacist before continuing.
Tracking Your Trend Over Time
A single eGFR of 42 is a snapshot. What matters more is the slope: how fast your kidney function is changing over months and years. If your eGFR has been stable at 42 for two years, your prognosis is very different from someone whose eGFR was 65 a year ago and 42 now. Ask your doctor to show you your eGFR trend over the past several lab draws. A decline of more than about 5 mL/min per year is considered rapid and should prompt a closer look at the underlying cause and whether treatment needs to be intensified.
Seasonal and day-to-day variation is real. Hydration, recent meals, exercise, and even the time of day can shift your creatinine and therefore your eGFR by a few points. A reading of 42 one month and 45 the next does not mean your kidneys improved; that is normal fluctuation. Look at the overall direction over six months to a year, and resist the urge to celebrate or despair over every individual lab draw.